Our Investors Support Bold Initiatives

Cowen and Company 38th Annual Health Care Conference

On Monday, March 12, 2018 at 4:50 p.m. Eastern Time, Michael Pehl, President and Chief Executive Officer, will present an overview of the Company at Cowen and Company 38th Annual Health Care Conference

Sign up for the Latest Information from Immunomedics

Annual Report

Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases.

icon of page with pie chart on it

Explore Resources for Current and Prospective Investors

Explore Resources